Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 28, 2021, the board of directors and shareholders removed Larson
Elsmore as Vice Chairman, CFO, Secretary and Director. On the same date, the
board of directors appointed Timothy Rogers as Interim CFO and Seamus McAuley as
the company's Secretary.
Also on September 28, 2021, the board of directors appointed Hunter Land to
serve as Director and Vice President of Translational Research.
Also on September 28, 2021, the board of directors resolved to terminate all
existing advisory boards of the company and to establish an Audit and Compliance
Committee, with Ning Qu to serve as Chairperson.
The board of directors has also adopted a charter for the Audit and Compliance
Committee, which is attached as Exhibit 99.1, and incorporated herein by
Timothy Paul Rogers - Age 57
The employment history for Mr. Rogers is contained in Form 10-KT filed with the
SEC on June 9, 2021.
Seamus McAuley - Age 45
The employment history for Mr. McAuley is contained in Form 10-KT filed with the
SEC on June 9, 2021.
Hunter Land - Age 37
Hunter Land has over 20 years of R&D expertise across 15 different indications,
as well as 10 years of cannabinoid-focused research. As an expert in the field
of cannabinoid science, he has developed a pipeline of discovery work on over 20
novel cannabinoids and terpenes. Previously, Hunter acted as the Sr. Scientific
Director, Director of Cannabinoid Research, and scientific spokesperson at
Canopy Growth Corporation. Most notably, Hunter co-established R&D for GW
Pharmaceuticals within the US, where he authored multiple protocols in
refractory epilepsy (Dravet Syndrome and Lennox-Gastaut Syndrome), Multiple
Sclerosis, pain, and led the clinical development of Epidiolex® (FDA approved
prescription CBD). Hunter acts as the Sr. Scientific Advisor for the National
Hockey League Alumni Association in conjunction with NEEKA Brain Health, a board
member of Veterinary Cannabis Society, and lectures at the University of
Wisconsin. He has been a featured speaker at over 50 scientific conferences, a
named inventor on 6 patent applications, and has over 20 publications.
Mr. Land has not had any direct or indirect interest in any transaction in the
past two years involving the company.
© Edgar Online, source Glimpses